Systems Biology Opens the Blackest Boxes
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Biofirms Develop Novel Therapeutics for MS
Major Research Focus is on T Cells
- Acorda Therapeutics (www.acorda.com) recently completed enrollment of its Phase III trial of Fampridine-SR in multiple sclerosis (MS). The study, which is based on a Special Protocol Assessment issued by the FDA, is evaluating the safety and efficacy of Fampridine-SR in improving walking ability in people with MS. Secondary outcomes ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.